aClinical Trials Unit, Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana;

bStatistical and Data Analysis Center, Harvard University T. H. Chan School of Public Health, Boston, MA;

cDivision of Infectious Diseases, University of Pennsylvania, Philadelphia, PA;

dDurban International CRS, Enhancing Care Foundation, Durban, South Africa;

eDivision of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL;

fDepartment of Pediatrics, Medicine and Pathology, Molecular and Virology Clinical Laboratories, University of Colorado Denver, Colorado, CO;

gAsociacion Civil Impacta Salud y Educacion, Peru Clinical Trials Unit, Lima, Peru;

hDepartment of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA;

iClinical Trials Research Centre, Department of Medicine, University of Zimbabwe, Harare, Zimbabwe;

jDepartment of International Public Health, Liverpool School of Tropical Medicine, Liverpool, United Kingdom; and

kDivision of Infectious Diseases, Brigham and Women's Hospital and Department of Immunology and Infectious Disease, Harvard T. H. Chan School of Public Health, Boston, MA.

Correspondence to: Ayotunde E. Omoz-Oarhe, MBBS, MPH, Botswana Harvard AIDS Institute Partnership, Clinical Trials Unit (CTU), Private Bag BO320, Gaborone, Botswana (e-mail: [email protected]).

Supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number UM1 AI068634, UM1 AI068636, U01 AI069471, and UM1 AI106701. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health

The authors have no funding or conflicts of interest to disclose.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.jaids.com).